9. Former name or former address, if changed since last report
N/A
10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA
Title of Each Class
Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common Shares
39,677,394,773
Series A Preferred Shares
8,341,500
Series B Preferred Shares
16,658,500
11. Indicate the item numbers reported herein
Item 9 - Other Events
The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.
ACEN CORPORATIONACEN
PSE Disclosure Form 14-1 - Notice of Analysts'/Investors' Briefing References: Section 14 of the Revised Disclosure Rules
Subject of the Disclosure
Notice of Analysts’ and Investors’ Briefing on 9 November 2023
Background/Description of the Disclosure
Please be informed that ACEN will conduct an Analyst and Investor Briefing on the company’s financial and operating results for the first nine months of 2023 on 9 November 2023, Thursday, at 4:00 p.m.
The briefing will be done via a hybrid setup.
Type of Briefing
Analyst and Investor Briefing
Subject of the Briefing
ACEN Financial & Operating Results for the first Nine Months of 2023
Date of the Briefing
Nov 9, 2023
Time
4:00 p.m.
Venue
Hybrid, via video conference and limited in-person attendance at the ACEN Head Office, 35/F Ayala Triangle Gardens Tower 2, Paseo de Roxas cor. Makati Avenue, Makati
Analysts and investors who intend to participate in the briefing should confirm their attendance via email to [email protected] on or before the close of business on 6 November 2023, Monday. Registration details will be provided to guests who have confirmed.